Fig. 5: Heatmaps. | Nature Communications

Fig. 5: Heatmaps.

From: Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

Fig. 5: Heatmaps.The alternative text for this image may have been generated using AI.

Panel A (n = 89 patients) shows hierarchical co-clustering of clinical variables and baseline serum cytokine levels in the overall cohort. Levels of correlation of each cytokine with the other ones in arm A (panel B, n = 27 patients), in arm B (panel C, n = 28 patients), in arm C (panel D, n = 34 patients). The setting for the visible lower and upper scale bounds is two standard deviations (ANOVA was used for comparison of groups). *shows unavailable cytokines.

Back to article page